SCHEMBL2782203

SCHEMBL2782203

OC(Cc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1

nearest known ligand 0.75

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 20/20 0.75
PDE4B Q07343 20/20 0.75
PDE4C Q08493 20/20 0.75
PDE4D Q08499 20/20 0.75
ABCB11 O95342 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29723157 1.00 PDE4A (0.75) PDE4APDE4BPDE4CPDE4DABCB11
SCHEMBL13212480 1.00 PDE4A (0.75) PDE4APDE4BPDE4CPDE4DABCB11
SCHEMBL14165062 1.00 PDE4A (0.75) PDE4APDE4BPDE4CPDE4DABCB11
SCHEMBL15786231 1.00 PDE4A (0.75) PDE4APDE4BPDE4CPDE4DABCB11
SCHEMBL19673799 0.93 PDE4A (0.66) PDE4APDE4BPDE4CPDE4DABCB11
SCHEMBL14839488 0.93 PDE4A (0.66) PDE4APDE4BPDE4CPDE4DABCB11
SCHEMBL14839643 0.93 PDE4A (0.66) PDE4APDE4BPDE4CPDE4DABCB11
SCHEMBL13232717 0.89 PDE4D (0.60) PDE4APDE4BPDE4CPDE4DABCB11
SCHEMBL13212454 0.89 PDE4A (0.78) PDE4APDE4BPDE4CPDE4D
SCHEMBL28759831 0.89 PDE4D (0.65) PDE4APDE4BPDE4CPDE4DABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9056176-B2 1-phenyl-2-pyridinyl alkyl alcohol compounds as phosphodiesterase inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2015-06-16 US disclosed
US-20140378423-A1 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2014-12-25 US disclosed
US-8859778-B2 1-phenyl-2-pyridinyl alkyl alcohol compounds as phosphodiesterase inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2014-10-14 US disclosed
EP-2760838-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2014-08-06 EP disclosed
US-20140179647-A1 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2014-06-26 US disclosed
US-8648204-B2 1-phenyl-2-pyridinyl alkyl alcohol compounds as phosphodiesterase inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2014-02-11 US disclosed
US-20130289010-A1 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMA SPA (IT) 2013-10-31 US disclosed
US-8440834-B2 1-phenyl-2-pyridinyl alkyl alcohol compounds as phosphodiesterase inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2013-05-14 US disclosed
WO-2013045280-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2013-04-04 WO disclosed
US-20130012487-A1 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2013-01-10 US disclosed
EP-2393782-B1 BENZOIC ACID (1-PHENYL-2-PYRIDIN-4-YL) ETHYL ESTERS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMA SPA (IT) 2012-09-12 EP disclosed
EP-2393782-A1 BENZOIC ACID (1-PHENYL-2-PYRIDIN-4-YL) ETHYL ESTERS AS PHOSPHODIESTERASE INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2011-12-14 EP disclosed
WO-2010089107-A1 BENZOIC ACID (1-PHENYL-2-PYRIDIN-4-YL) ETHYL ESTERS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2010-08-12 WO disclosed
US-20100204256-A1 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2010-08-12 US disclosed
EP-2216327-A1 Benzoic acid (1-phenyl-2-pyridin-4-yl)ethyl esters as phosphodiesterase inhibitors CHIESI FARMACEUTICI S.p.A. (IT) 2010-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204256-A1 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS PDE4A, PDE4B, PDE3A PDE4A 1/4885PDE4B 2/4885PDE4C 7/4885
US-20130289010-A1 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS PDE4A, PDE4B, PDE3A PDE4A 1/4885PDE4B 2/4885PDE4C 7/4885
US-20130012487-A1 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS PDE4A, PDE4B, PDE3A PDE4A 1/4885PDE4B 2/4885PDE4C 7/4885
US-20140378423-A1 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS PDE4A, PDE4B, PDE3A PDE4A 1/4885PDE4B 2/4885PDE4C 7/4885
US-20140179647-A1 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS PDE4A, PDE4B, PDE3A PDE4A 1/4885PDE4B 2/4885PDE4C 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.